Investegate |Pharnext Announcements | Pharnext: Pharnext strengthens its management team with three key appointments to support ongoing development of PXT3003 toward approval and commercialization

Investegate announcements from Pharnext, Pharnext strengthens its management team with three key appointments to support ongoing development of PXT3003 toward approval and commercialization

Related Keywords

United States ,India ,Paris ,France General ,France ,Abhijit Pangu ,Sukaina Virji ,Xavier Paoli ,Ghislaine Gasparetto ,Mary Jane Elliott ,Frontida Biopharm ,Alexandra Harrison ,Raj Thota ,Xavier University United States ,Glaxosmithkline ,Alexion Pharmaceuticals ,Villanova University ,Euronext Growth Stock Exchange ,University Denis Diderot Paris ,Regulatory Affairs Certification ,Business School Paris ,Media Relations International ,Regulatory Affairs Professional Society ,Consilium Strategic Communications ,Head Of Regulatory Affairs ,Chief Manufacturing Officer ,Regulatory Affairs ,Chief Operating ,Vice President ,General Manager ,Pharmaceutical Technology ,Xavier University United ,Lean Six Sigma Greenbelt Certification ,Senior Consultant ,Chief Operating Officer ,Commercialization Strategy Director ,Chief Commercial Officer ,University Denis Diderot ,Horn Solomon ,Chief Executive Officer ,Investegate Announcements ,Investegate Company Announcements ,Pharnext ,Qs ,Qs And Eqs ,